Unichem Laboratories shines on getting ANDA nod for Carbamazepine Tablets
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Unichem Laboratories is currently trading at Rs. 293.00, up by 8.10 points or 2.84% from its previous closing of Rs. 284.90 on the BSE.
The scrip opened at Rs. 282.80 and has touched a high and low of Rs. 294.90 and Rs. 282.80 respectively. So far 3483 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 322.00 on 19-Jan-2022 and a 52 week low of Rs. 197.50 on 22-Nov-2021.
Last one week high and low of the scrip stood at Rs. 297.80 and Rs. 277.60 respectively. The current market cap of the company is Rs. 2065.00 crore.
The promoters holding in the company stood at 50.93%, while Institutions and Non-Institutions held 11.03% and 38.04% respectively.
Unichem Laboratories has received ANDA approval for its Carbamazepine Tablets USP, 200 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TEGRETOL (Carbamazepine) Tablet, 200 mg of Novartis Pharmaceuticals Corp. Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia. The product will be commercialized from Unichem’s Goa Plant.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company.
